Home Editor's Blog News Special Reports Directory Events Advertise Submit Your News About Us Guides News by Zone I News by Date I News by Category   Home News By Category Biomaterials and biopharmaceuticals Free Newsletter Register for our Free Newsletters Zones Analysis, Inspection and Laboratory Assisted/Independent Living Clinical and Nursing Equipment Design and Manufacture of Medical Equipment Diagnostics Equipment, Monitoring and Test Education, Training and Professional Services Health Education and Patient Management Health Estates Management Healthcare Support and Information Services Hygiene and Infection Control IT and Communications in Healthcare Materials Medical Device Technology Research and Development Safety and Security View All Other Carouselweb publications   Biomaterials and biopharmaceuticals ThromboGenics partners Alcon to launch ophthalmic medicines in Denmark and Sweden Biomaterials and biopharmaceuticals : 29 May, 2013 ThromboGenics, an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines, is partnering Alcon to launch JETREA in Denmark and Sweden, the third and fourth European markets where the product is now available.   [ View Detail ] Nordion signs contract manufacturing deal with Navidea Biopharmaceuticals for diagnostic imaging agent Biomaterials and biopharmaceuticals : 17 May, 2013 Nordion signs a contract manufacturing agreement with Navidea Biopharmaceuticals, a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals.   [ View Detail ] OncoSec collaborates with Smart Patients to create online community for patients Biomaterials and biopharmaceuticals : 22 April, 2013 OncoSec Medical is one of the first to partner with Smart Patients: a new online community where patients with life-threatening conditions who are looking for or participating in clinical trials can share their feedback and experiences.   [ View Detail ] InVivo Therapeutics receives FDA approval for first human trial using biomaterials for traumatic spinal cord injury Biomaterials and biopharmaceuticals : 08 April, 2013 The US Food and Drug Administration (FDA) has approved InVivo Therapeutics' Investigational Device Exemption (IDE) to begin human studies to test its biopolymer scaffold product, a technology developed to treat patients with acute, traumatic SCI.   [ View Detail ] Bone Therapeutics receives manufacturing authorisation to produce allogeneic bone cell therapy products Biomaterials and biopharmaceuticals : 26 March, 2013 Bone Therapeutics receives both 'Tissue Establishment' and 'GMP' Accreditation for the manufacturing of the company's ALLOB allogeneic bone cell therapy product, being initially developed for the treatment of impaired fractures.   [ View Detail ] Medisse raises more funding for adhesion barrier solution Biomaterials and biopharmaceuticals : 30 January, 2013 Medisse closes a Series B equity financing round of 2.6 milion euros for the clinical trial of the company's lead product FlexiSurge Adhesion Barrier.   [ View Detail ] Dyax agrees Kadmon strategic licensing agreement for DX-2400 Biomaterials and biopharmaceuticals : 21 September, 2012 Dyax is entering into a strategic licensing agreement with Kadmon which will see Kadmon being granted an exclusive worldwide license for the development and commercialization of the fully human monoclonal antibody DX-2400, a potent and selective antibody inhibitor of matrix metalloproteinase 14 (MMP-14).   [ View Detail ] SafeStitch Medical agrees with Herniamesh to distribute mesh Biomaterials and biopharmaceuticals : 01 August, 2012 SafeStitch Medical is entering in a distribution agreement with Herniamesh, an Italian mesh manufacturer operating in the biomedical market, to distribute mesh used for inguinal and ventral hernia repair in the USA.   [ View Detail ] Prosonix partners Imperial College London to develop engineered combination respiratory medicines Biomaterials and biopharmaceuticals : 06 July, 2012 Prosonix (Oxford, UK) signs a Collaborative Research Agreement with Imperial College London to accelerate the development of engineered Multi-component Particles (MCPs) as respiratory medicines.   [ View Detail ] Olympus unveils dissolvable post sinus surgery products Biomaterials and biopharmaceuticals : 09 January, 2012 Olympus is adding a broad line of advanced, dissolvable sinus spacing and haemostat products to the company's extensive ENT product portfolio.   [ View Detail ] Cardium agrees deal for commercialization of Excellagen in South Korea Biomaterials and biopharmaceuticals : 09 January, 2012 Cardium Therapeutics is entering into the company's first international agreement for the commercialization of Excellagen in the South Korean market.   [ View Detail ] Quintiles acquires VCG and Associates plus VCG Bio Biomaterials and biopharmaceuticals : 21 October, 2011 Quintiles completes the acquisition of VCG and Associates and VCG BIO, based in Holliston, Massachusetts, and Cave Creek, Arizona, respectively.   [ View Detail ] Bio-compatible 3D printing material provides medical solutions Biomaterials and biopharmaceuticals : 23 September, 2011 Objet launches a new bio-compatible 3D printing material (MED610) that combines bio-compatibility with high dimensional stability and clear transparency making it useful for PMMA simulation and a wide range of medical and dental applications - particularly the production of highly accurate, customised surgical guides.   [ View Detail ] Irvine Scientific begins industrial cell culture media shipments in Japan Biomaterials and biopharmaceuticals : 25 August, 2011 Irvine Scientific, a member of JX Holdings group, begins shipping the first products manufactured to customers from its Industrial Cell Culture media production facility in Tokyo, Japan.   [ View Detail ] GE Healthcare plans acquisition of PAA Laboratories Biomaterials and biopharmaceuticals : 18 August, 2011 GE Healthcare agrees to acquire PAA Laboratories, a developer and supplier of cell culture media for biomedical research and the fast-growing biopharmaceutical and vaccine manufacturing industry.   [ View Detail ] Quintiles to fund an adaptive clinical trial to develop breast cancer therapies Biomaterials and biopharmaceuticals : 18 April, 2011 Quintiles is to contribute a total of $2.6 million over four years to support I-SPY 2, an adaptive clinical trial designed to develop breast cancer therapies twice as quickly and at one-fifth the cost of current methods.   [ View Detail ] New spine sealant from Covidien is approved by the US FDA Biomaterials and biopharmaceuticals : 15 April, 2011 Covidien’s DuraSeal Exact spine sealant is approved by the US Food and Drug Administration (FDA).   [ View Detail ] Surgical sealant receives CE Mark and targets lung resection surgery Biomaterials and biopharmaceuticals : 12 January, 2011 Neomend receives the CE Mark for the company’s ProGEL PLATINUM Surgical Sealant.   [ View Detail ] Medtronic acquires Osteotech to boost regenerative biologics performance Biomaterials and biopharmaceuticals : 19 November, 2010 Medtronic completes the acquisition of Osteotech, following payment of $6.50 per share in cash for each share of Osteotech stock, with a total transaction value of approximately $123 million.   [ View Detail ] Cephalon agrees funding deal with ChemGenex for omacetaxine for CML patients Biomaterials and biopharmaceuticals : 26 October, 2010 Cephalon signs a convertible note subscription agreement with ChemGenex Pharmaceuticals, an Australian-based oncology focused biopharmaceutical company.   [ View Detail ] Novozymes offers free evaluation samples of Bacillus-based sodium hyaluronate Biomaterials and biopharmaceuticals : 07 July, 2010 Novozymes Biopharma is offering its customers free evaluation samples of the company's award-winning Bacillus-based sodium hyaluronate.   [ View Detail ] AdvanSource’s polymer products comply with EC’s new TSE guidelines Biomaterials and biopharmaceuticals : 10 February, 2010 AdvanSource Biomaterials, a developer of advanced polymer materials for a broad range of medical devices, declares that its polymer product lines are compliant with measures applying to the processing of certain animal waste to protect against transmissible spongiform encephalopathies as set forth in European Council Decision 1999/534/EC.   [ View Detail ] PolyTherics to develop novel biopharmaceutical molecule Biomaterials and biopharmaceuticals : 27 January, 2010 Leverton Licence Holdings (LLH), a wholly-owned subsidiary of CP2, is investing into a research programme to develop a novel biopharmaceutical molecule.   [ View Detail ] Pall acquires MicroReactor Technologies Biomaterials and biopharmaceuticals : 14 January, 2010 Pall acquires MicroReactor Technologies(MRT), a privately held US biotechnology company. MRT has developed a reliable, easy-to-use and cost-effective miniature bioreactor technology platform.   [ View Detail ] Biomerix biomaterial manufacturing sites receive ISO 13485 recognition Biomaterials and biopharmaceuticals : 16 June, 2009 Biomerix, a medical technologies company developing products using its novel Biomerix Biomaterial, a three-dimensional scaffold for biointegrative tissue repair, receives an ISO 13485 Certificate of Registration.   [ View Detail ] New cGMP facility produces bacillus-based hyaluronic acid Biomaterials and biopharmaceuticals : 29 April, 2009 Novozymes Biopharma, part of Novozymes, is constructing a new cGMP facility at the company's existing site in Tianjin, China that will enable its novel form of Bacillus-based Hyaluronic Acid (bHA), HyaCare, to be used within the bio-medical and pharmaceutical industries.   [ View Detail ] Bioresorbable film receives US FDA pre-market approval for paediatric cardiac surgery Biomaterials and biopharmaceuticals : 10 March, 2009 The US Food and Drug Administration (FDA) has approved the Pre-market Approval (PMA) application for SyntheMed’s REPEL-CV Adhesion Barrier for use in paediatric cardiac surgery patients.   [ View Detail ] Study spotlights the osteoconductive properties of Trabecular Metal Technology Biomaterials and biopharmaceuticals : 26 February, 2009 Data has been released from an independent 10-year comparative clinical study that demonstrates the osteoconductive properties of Zimmer's Trabecular Metal Technology.   [ View Detail ] CPC Scientific to offer Sigma-Aldrich's PEPscreen custom peptide libraries Biomaterials and biopharmaceuticals : 02 February, 2009 CPC Scientific, a leading provider of custom peptide synthesis, GMP peptides and peptide APIs has signed a distribution agreement with Sigma-Aldrich.   [ View Detail ] Parexel International opens Peru office to extend Latin American coverage Biomaterials and biopharmaceuticals : 21 November, 2008 Parexel International has opened an office in Lima, Peru to provide regulatory consulting and clinical research capabilities.   [ View Detail ] SyntheMed receives FDA 510(k) clearance to market SinusShield bioresorbable membrane Biomaterials and biopharmaceuticals : 20 November, 2008 SyntheMed has received FDA 510(k) clearance to market SinusShield, a bioresorbable membrane intended to prevent post-operative adhesions in nasal and sinus surgical procedures.   [ View Detail ] Debiopharm partners Ecole Polytechnique Federale de Lausanne in stem cell project Biomaterials and biopharmaceuticals : 03 September, 2008 Debiopharm Group has signed a research project agreement with the Ecole Polytechnique Federale de Lausanne (EPFL), which is aimed at the identifying novel small molecules and peptides that interfere with pathways controlling cell fate specification.   [ View Detail ] Telik's small molecule proteasome inhibitor programme demonstrates anticancer activity Biomaterials and biopharmaceuticals : 22 August, 2008 Telik’s novel small molecule proteasome inhibitor programme has met a preclinical development milestone by demonstrating anticancer activity in preclinical models of human leukemia.   [ View Detail ] ETEX launches orthobiologic bone graft substitute Biomaterials and biopharmaceuticals : 18 August, 2008 ETEX has launched an innovative orthobiologic called EquivaBone which is a bone graft substitute that remodels and is replaced with new bone during the healing process.   [ View Detail ] Tissue culture range overcomes in vitro cell culture difficulties Biomaterials and biopharmaceuticals : 18 July, 2008 The Iwaki range of tissue culture products from Sterilin consists of standard non-treated and tissue culture treated ware and features a range of substrate coated products developed to combat problems associated with in vitro cell culture.   [ View Detail ] PolyTherics to collaborate with Alligator Bioscience to develop new biopharmaceuticals Biomaterials and biopharmaceuticals : 16 June, 2008 PolyTherics and Alligator Bioscience have established a new alliance which will see both companies collaborate to explore the biological effects of the polymer-based technologies developed by PolyTherics on proteins optimised and provided by Alligator.   [ View Detail ] CardioTech forms new biomaterials subsidiary Biomaterials and biopharmaceuticals : 02 June, 2008 CardioTech International has formed AdvanSource Biomaterials to conduct its business and align its name with its strategic focus.   [ View Detail ] Polytherics receives European patent for polymer complexation technology Biomaterials and biopharmaceuticals : 28 May, 2008 Polytherics has been granted a European patent on the application of polymer complexation technology to improve drug efficacy.   [ View Detail ] ETEX agrees a supply deal with AlloSource for DBM powder Biomaterials and biopharmaceuticals : 25 April, 2008 Advanced biomaterials company, ETEX has entered into a supply agreement with AlloSource which will see AlloSource provide ETEX with Demineralized Bone Matrix (DBM) powder to be mixed with ETEX's proprietary, nanocrystalline, fast setting calcium phosphate to form EquivaBone.   [ View Detail ] FDA fast tracks synthetic human secretin for pancreatic imaging Biomaterials and biopharmaceuticals : 17 April, 2008 The US Food and Drug Administration (FDA) has granted Fast Track designation to the development programme for Repligen’s RG1068, synthetic human secretin, to improve the assessment of pancreatic duct structures by magnetic resonance imaging (MRI).   [ View Detail ]

Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides      © 2012 ProHealthServiceZone.com